Postdoctoral Research Fellow (Drug Product Technical Services) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Wave Life Sciences · 12 hours ago

Postdoctoral Research Fellow (Drug Product Technical Services)

Wave Life Sciences is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. They are hiring a Postdoctoral Research Fellow to develop oligonucleotide drug products for multiple clinical programs, providing exposure to the drug development lifecycle within a cross-functional team environment.

BiotechnologyHealth CarePharmaceuticalTherapeutics
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Design and execute formulation development studies to optimize oligonucleotide DP formulations
Conduct pre-formulation studies to assess physicochemical properties of various excipients and identify potential issues
Investigate the stability of formulations under different conditions and apply biophysical and analytical techniques to characterize molecular interactions and their impact on stability
Develop and implement analytical methods for characterizing oligonucleotide drug products using techniques such as pH meter, Osmometer, Densitometer, HPLC/UPLC, UV spectrophotometry/ Solo VPE, lyophilizer, DSC (Hands on experience on these instruments preferred)
Evaluate and implement new technologies for formulation improvement ensuring compliance with clinical and regulatory requirements
Collaborate with cross-functional teams within CMC to achieve project goals and assist with technology transfer activities at CMO
Present research findings at internal meetings and conferences
Maintain detailed records of experiments in Lab notebooks
Complete training and certifications on GLP practices and possess excellent literature review skills while sharing expertise with the team
Author and review technology transfer documentation including process descriptions, risk assessments, comparability protocols, and batch records
Participate in process scale-up, troubleshooting and root cause investigations during tech transfer campaigns

Qualification

Oligonucleotide drug developmentAnalytical techniquesFormulation developmentPharmaceutical Sciences Ph.D.Regulatory knowledgeScientific curiosityProblem-solving skillsCommunication skillsTeam collaboration

Required

Ph.D. in Pharmaceutical Sciences, Chemistry, Biochemistry, Chemical Engineering, or a related field
Strong background in drug product and formulation development, preferably with experience in oligonucleotide therapeutics
Proficiency in various analytical techniques used in formulation development
Experience with different formulation development strategies for parenteral delivery
Excellent problem-solving and data analysis skills
Strong communication skills for presenting scientific data
Ability to work independently and collaboratively in a team environment
Demonstrated scientific curiosity and a passion for advancing RNA medicines
Knowledge of applicable regulatory and quality standards (ICH, FDA, EMA) is desired

Benefits

Company-sponsored medical, dental, vision, life, long and short-term disability insurances
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
401K participation with matching contributions

Company

Wave Life Sciences

twittertwittertwitter
company-logo
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

H1B Sponsorship

Wave Life Sciences has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (15)
2024 (11)
2023 (15)
2022 (16)
2021 (15)
2020 (15)

Funding

Current Stage
Public Company
Total Funding
$1.22B
Key Investors
GlaxoSmithKlineTakeda VenturesForesite Capital
2025-12-09Post Ipo Equity· $350M
2024-09-24Post Ipo Equity· $200M
2023-12-06Post Ipo Equity· $100M

Leadership Team

leader-logo
Paul Bolno
President and CEO
linkedin
C
Chandra Vargeese
Chief Technology Officer and Head of Platform Discovery Sciences
linkedin
Company data provided by crunchbase